The pivotal role of phosphatidylinositol 3-kinase (PI 3-kinase) in signal transduction has been well established in recent years. Receptor-regulated forms of PI 3-kinase are thought to phosphorylate phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P 2 ) at the 3-position of the inositol ring to give the putative lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P 3 ). Cellular levels of PtdIns(3,4,5)P 3 are currently measured by time-consuming procedures involving radiolabeling with high levels of 32 PO 4 , extraction, and multiple chromatography steps. To avoid these lengthy and hazardous procedures, many laboratories prefer to assay PI 3-kinase activity in cell extracts and/or appropriate immunoprecipitates. Such approaches are not readily applied to measurements of PtdIns(3,4,5)P 3 in extracts of animal tissues. Moreover, they can be misleading since the association of PI 3-kinases in molecular complexes is not necessarily correlated with the enzyme's activity state. Direct measurements of PtdIns(3,4,5)P 3 would also be desirable since its concentration may be subject to additional control mechanisms such as activation or inhibition of the phosphatases responsible for PtdIns(3,4,5)P 3 metabolism. We now report a simple, reproducible isotope dilution assay which detects PtdIns(3,4,5)P 3 at subpicomole sensitivity, suitable for measurements of both basal and stimulated levels of PtdIns(3,4,5)P 3 obtained from samples containing approximately 1 mg of cellular protein. Total lipid extracts, containing PtdIns(3,4,5)P 3 , are first subjected to alkaline hydrolysis which results in the release of the polar head group Ins(1,3,4,5)P 4 . The latter is measured by its ability to displace [ 32 P]Ins(1,3,4,5)P 4 from a highly specific binding protein present in cerebellar membrane preparations. We show that this assay solely detects PtdIns(3,4,5)P 3 and does not suffer from interference by other compounds generated after alkaline hydrolysis of total cellular lipids. Measurements on a wide range of cells, including rat-1 fibroblasts, 1321N1 astrocytoma cells, HEK 293 cells, and rat adipocytes, show wortmannin-sensitive increased levels of PtdIns(3,4,5)P 3 upon stimulation with appropriate agonists. The enhanced utility of this procedure is further demonstrated by measurements of PtdIns(3,4,5)P 3 levels in tissue derived from whole animals. Specifically, we show that stimulation with insulin increases PtdIns(3,4,5)P 3 levels in rat skeletal muscle in vivo with a time course which parallels the activation of protein kinase B in the same samples.
PI 3-kinases
1 represent a family of enzymes which phosphorylate phosphoinositides on the 3-position of the inositol ring (1) . The role of PI 3-kinases in mitogenic signaling, membrane ruffling, trafficking, cell motility, inflammatory and immune cell responses, activation of neutrophils, and the metabolic effects of insulin (2-8) has been well established using biochemical, pharmacological, and genetic approaches. At least two major classes of PI 3-kinases have been identified which differ in their substrate specificity. Agonist-stimulated forms of PI 3-kinase can utilize PtdIns, PtdIns 4-phosphate, and PtdIns(4,5)P 2 as substrates in vitro (9, 10) , but several lines of evidence suggest that PtdIns(4,5)P 2 is the preferred substrate in intact cells (11, 12) . The resulting PtdIns(3,4,5)P 3 has been shown to increase rapidly and transiently in many cells in response to a wide variety of stimuli and since there are no known phospholipases that can metabolize this lipid (13) , it has been suggested that PtdIns(3,4,5)P 3 itself is a second messenger. At present there are reports that PtdIns(3,4,5)P 3 can activate atypical forms of protein kinase C (14) and can bind to protein kinase B (also named Akt or Rac) (15) (16) (17) and the recently cloned centaurin (18) , encoding for a novel gene, which is highly expressed in brain and which shows homology to yeast and mammalian Arf GTPase-activating proteins.
Measuring PtdIns(3,4,5)P 3 levels has so far been done by labeling cells with [ 3 H]inositol or [ 32 P]orthophosphate. Cell labeling with inositol is often not very efficient, and labeling to isotopic equilibrium can take days. Labeling cells with [ 32 P]orthophosphate is inconvenient because of the precautions needed for the large amounts of radioactivity required. Both labeling procedures suffer from the drawback of elaborate, expensive and time-consuming HPLC analysis of deacylated lipid extracts which are required to resolve the glycerol derivative, GroPtdIns(3,4,5)P 3 , from 32 P-labeled contaminants. We therefore developed a straightforward, highly specific and sensitive method that allows the detection of picomole amounts of PtdIns(3,4,5)P 3 . The assay is based on cleavage of the polar head group of PtdIns(3,4,5)P 3 to yield Ins(1,3,4,5)P 4 , the mass of which can be measured using an isotope dilution assay with a sensitivity limit of approximately 0.3 pmol. In general, lipid extracts from samples containing 1 mg of cellular protein are sufficient for determination of the level of PtdIns(3,4,5)P 3 . The preparation of a highly specific Ins(1,3,4,5)P 4 -binding protein (obtained from sheep cerebellum) and high specific activity P]Ins(1,3,4,5)P 4 (prepared from Ins(1,4,5)P 3 and [␥- 32 P]ATP using a recombinant Ins(1,4,5)P 3 3-kinase from rat brain) are described. We show that measurements of PtdIns(3,4,5)P 3 mass determined by isotope dilution match well with measurements from isotopic equilibrium cell labeling experiments. Furthermore, the assay can be applied in situations where radioactive labeling is impractical. Insulin administration to anesthetized rats resulted in a rapid increase of PtdIns(3,4,5)P 3 levels, which was paralleled by an increase in PKB activity, in extracts from freeze-clamped hind limb skeletal muscle. with the cloned DNA insert (C5), was used to inoculate LB medium supplemented with 50 g/ml ampicillin at 37°C to an A 600 of 1.5. The culture was then diluted to an A 600 of 0.5 with fresh prewarmed medium (30°C), and expression was induced by the addition of isopropyl-␤-D-thiogalactopyranoside (1 mM) after which the cells were grown for an additional 2 h at 30°C. Bacteria were harvested (1200 ϫ g, 15 min) and resuspended in cold lysis buffer (50 mM Tris-HCl, pH 8.0, 1 mM EDTA, 0.4 mM phenylmethylsulfonyl fluoride, 0.4 mM benzamidine, 5 M leupeptin, 5 M pepstatin, and calpain inhibitors I and II at 5 g/ml). After sonication in ice, Triton X-100 was added to a final concentration of 1% (v/v) and the lysate was shaken for 1 h at 4°C. After a 30-min centrifugation at 15,000 ϫ g, the supernatant was applied to a CaM-affinity column which was eluted as described in Ref. 20 32 P]ATP (3000 Ci/mmol), and 20 l of enzyme, was incubated for 1 h at 37°C, and the reaction was terminated by the addition of 0.8 ml of 10 mM EDTA followed by 2 min of boiling. The sample was applied to a HPLC Partisphere-SAX column, eluted with a nonlinear gradient made of water and 1.0 M NH 4 H 2 PO 4 (pH 3.8). Fractions (2 ml) containing [3- 32 P]Ins(1,3,4,5)P 4 were identified by Cerenkov counting, pooled, and dialyzed 3 times against 1000 ml of water for 45 min (the desalting of inositol polyphosphates by dialysis is described in more detail in Ref. 21 ). This effectively removed the inorganic phosphate which would otherwise interfere in the Ins(1,3,4,5)P 4 binding assay. The recovery of [ 32 P]Ins(1,3,4,5)P 4 following dialysis was approximately 50%. Starting with 100 M Ins(1,4,5)P 3 and 1 mCi of [␥-
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32 P]ATP (ϳ3000 Ci/mmol), 0.5 mCi of [ 32 P]Ins(1,3,4,5)P 4 with a specific radioactivity of ϳ3000 Ci/mmol was routinely produced.
Preparation of Lipid Extracts-1321N1 Astrocytoma cells were grown to confluence on 6-well plates as described previously (22) . Prior to treatment, cells were washed twice with modified Krebs-Henseleit buffer and incubated in this buffer for 30 min at 37°C (22) . Cells were treated for 7.5 min with dimethyl sulfoxide carrier or wortmannin (100 nM) and then stimulated for 10 min with insulin (10 g/ml). The medium was aspirated and the cells were quenched with 1 ml of 10% trichloroacetic acid. After 15 min on ice, dishes were scraped and washed once with 0.5 ml of 10% trichloroacetic acid. The cell lysates were centrifuged for 5 min at 13,000 ϫ g, and the resulting pellet was washed twice with 0.5 ml of 5% trichloroacetic acid, 1 mM EDTA. Lipids were extracted in 0.75 ml of CHCl 3 /MeOH/HCl (40:80:1, by volume) for 20 min, and phases were then split by the addition of 0.25 ml of CHCl 3 and 0.45 ml of 0.1 M HCl. The lower phase, obtained after a 1-min centrifugation at 13,000 ϫ g, was transferred to a screw cap tube, and the upper phase was re-extracted once with 0.45 ml of the synthetic lower phase. The lower phases were pooled and dried down. Alkaline hydrolysis of dried lipids was carried out by vortexing in 50 l of 1.0 M KOH and boiling for 30 min. Following neutralization with 50 l of 1.0 M acetic acid, the fatty acids were removed by 2 extractions with 0.5 ml of water-saturated butan-1-ol/petroleum ether (40 -60°C)/ethyl acetate (20:4:1, by volume). Finally, the resulting water-soluble fractions were dried down and resuspended in 100 l of 0.2 M acetic acid, resulting in a 0.5 M potassium acetate solution with a final pH of 5.0, which could be used directly in the isotope dilution assay. The volumes could be adjusted to take into account the amount of cellular lipid present in each sample. As a general rule, samples which originally contained 1 mg of cell protein (about 0.3 mg of total lipid) could be efficiently hydrolyzed using the volumes of reagents noted above (see "Results and Discussion").
Ins (1, 3, 4, 5) P 4 Isotope Dilution Assay-The Ins(1,3,4,5)P 4 -binding protein was obtained from sheep cerebellum and prepared as described in Ref. 23 . Briefly, cerebella were homogenized in ice cold buffer (20 mM NaHCO 3 , pH 8.0, 1 mM dithiothreitol, 2 mM EDTA) and centrifuged for 10 min at 5000 ϫ g. The pellet was re-extracted once, and the pooled supernatants were centrifuged for 20 min at 38,000 ϫ g. The pellet was washed twice and resuspended in homogenization buffer at a final protein concentration of 10 -20 mg/ml.
Ins ( After addition of binding protein, samples were incubated on ice for 30 min and subsequently subjected to rapid filtration using GF/C filters. Filters were washed twice with 5 ml of ice cold buffer (25 mM NaAc, 25 mM KH 2 PO 4 , pH 5.0, 1 mM EDTA, and 5 mM NaHCO 3 ). Radioactivity was determined after the filters were extracted for 12 h in 4 ml of scintillant.
In Vivo Stimulation of Rats with Insulin-Male Wistar rats (200 g) were starved overnight and anesthetized with sodium pentobarbital, and one hind limb muscle was isolated prior to treatment. Rats were injected via the hind limb saphenous vein with 0.5 ml of 150 mM NaCl, containing propranolol (3.0 mg/kg) or propranolol (3.0 mg/kg) plus insulin (1.0 unit/kg). After various times, one hind limb skeletal muscle was freeze-clamped (with aluminum tongs cooled in liquid nitrogen), excised, and then powdered under liquid nitrogen using a precooled pestle and mortar. One gram of powdered muscle was used for the PtdIns(3,4,5)P 3 mass determination, and three rats were used for each time point. To each gram of powdered muscle, 10 ml of 10% trichloroacetic acid was added, and after 10 min the samples were centrifuged at 3000 rpm for 10 min. The pellets were washed and extracted as described above, but using 10 volumes of extraction solution. The extracted lipids were hydrolyzed in 0.8 ml of 1 M KOH, to account for the greater mass of starting material. Efficient hydrolysis was checked by HPLC analysis of spiked [
32 P]PtdIns(3,4,5)P 3 . For measurements of PKB activity, 1 g of powdered muscle was homogenized in 3 ml of ice-cold homogenization buffer (4 mM EDTA (pH 8.0), 50 mM NaF, 1.0 mM orthovanadate (pH 10.0), 1 M microcystin-LR, 0.1% ␤-mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride, and 1 mM benzamidine) using a Polytron homogenizer at 4°C. The homogenate was spun at 13,000 ϫ g for 10 min in a refrigerated centrifuge. Immunoprecipitation of PKB from 500 g of muscle extract and subsequent measurement of enzymatic activity was done as in Ref. 25 .
RESULTS AND DISCUSSION
Principles of the Assay-The assay procedure is based upon alkaline cleavage of a total cell phospholipid extract which generates Ins(1,3,4,5)P 4 from PtdIns(3,4,5)P 3 . The water-soluble head group can then be measured using a highly specific radioligand displacement assay. This approach, which avoids tedious chromatographic procedures, is based on a previously reported assay for PtdIns(4,5)P 2 , which utilized alkaline hydrolysis coupled to the radioligand displacement-based measurement of Ins(1,4,5)P 3 (26) .
In order to assess the utility of such an approach for analysis of PtdIns(3,4,5)P 3 , it was first necessary to determine the recovery of Ins(1,3,4,5)P 4 through the lipid extraction and hydrolysis procedures. The recovery of PtdIns(3,4,5)P 3 was analyzed by spiking tracer [
32 P]PtdIns(3,4,5)P 3 into total cell lipid extracts or lipids from Folch fraction I from bovine brain.
A single back-extraction of the upper phase of such extracts with synthetic lower phase (see "Experimental Procedures") was sufficient to recover 98% of the spiked radioactivity (not shown). The recovery of the radiolabeled Ins(1,3,4,5)P 4 was then followed by anion exchange HPLC analysis of the products. For these experiments, it was important to ensure an excess of KOH for hydrolysis of the ester bonds in the sample. Cell samples containing 1 mg of protein contain approximately 0.3 mg of lipid. Assuming an average molecular weight of 1000 and 3 susceptible bonds per mol of lipid, 50 l of 1 M KOH gives a 50-fold excess of hydroxyl ions. When this approach was applied to astrocytoma cell lipid extracts, HPLC analysis revealed 4 major peaks of radioactivity which accounted for Ͼ95% of the radioactivity applied to the column and which corresponded with the mobilities of Ins(3,4,5)P 3 (10.9 Ϯ 0.59%), GroPtdIns(3,4,5)P 3 (3.9 Ϯ 0.66%), Ins(1,3,4,5)P 4 (62 Ϯ 0.41%), and Ins(2,3,4,5)P 4 (24 Ϯ 1.2%). These are the expected products of alkaline hydrolysis of PtdIns(3,4,5)P 3 based on the original studies of PtdIns(4,5)P 2 hydrolysis by Brockerhoff and Ballou (27) . As expected, the recovery of Ins(1,3,4,5)P 4 through this procedure depended on the relative amounts of lipid and KOH. Thus, hydrolysis of 0.3 mg of astrocytoma cell lipids with 0.1 M and 0.5 M KOH yielded 17.0% and 52.4% Ins(1,3,4,5)P 4 , respectively. All subsequent experiments used 50 l of 1 M KOH to hydrolyze samples containing not more than 0.6 mg of lipid; the volume of 1 M KOH was increased correspondingly for samples containing greater amounts of lipid.
Selectivity and Sensitivity-Previous reports established the presence of highly specific Ins(1,3,4,5)P 4 binding sites in membranes prepared from mammalian cerebella and platelets (23, 24, 28) , which formed the basis of a radioreceptor assay for Ins(1,3,4,5)P 4 (24) . This assay requires a radioligand with a higher specific radioactivity than the commercially available [ When the above assay was applied to synthetic PtdIns(3,4,5)P 3 that had been subjected to alkaline hydrolysis, an apparent K d of 8.1 Ϯ 2.9 nM was obtained, consistent with the expected yield of Ins(1,3,4,5)P 4 of 62%. This suggests that none of the side-products of PtdIns(3,4,5)P 3 hydrolysis have a significant impact on displacement of the radioligand in the assay. This was established directly in the case of GroPtdIns(3,4,5)P 3 , which gave a K d of 7.6 Ϯ 1.72 nM, but amounts to less than 5% of the products of alkaline hydrolysis (see above).
Another issue to be dealt with was the affinity of the receptor for Ins(1,4,5)P 3 since this is the polar head group derived from alkaline hydrolysis of PtdIns(4,5)P 2 , which in unstimulated cells is usually present at a 1000-fold excess over PtdIns(3,4,5)P 3 (29) . As shown in Fig. 1, Ins(1,4,5 )P 3 did not displace any [ 32 P]Ins(1,3,4,5)P 4 at concentrations less than 1 M (confirming previous reports (23, 24, 28) ) and therefore is 3 or pmol of PtdIns(3,4,5)P 3 per one well of a six-well plate. The determined radioactivity and subsequent calculation of specific activity represent duplicates from at least two independent experiments (ND is not determined). The mass determinations were triplicates from 7 independent experiments, except the data for the inhibition with wortmannin which were from 2 independent experiments. Fig. 1 , was constructed for each experiment, and the assay values obtained for each sample were corrected for recovery of PtdIns(3,4,5)P 3 during extraction (98%) and yield of Ins(1,3,4,5)P 4 through alkaline hydrolysis (62%). To establish that displacement in the assay was due to authentic, cell-derived PtdIns(3,4,5)P 3 , we made use of a highly specific PtdIns(3,4,5)P 3 /Ins(1,3,4,5)P 4 -5-phosphatase that was partially purified from bovine brain.
2 A large scale lipid extract from astrocytoma cells was hydrolyzed as described above. The resulting sample was dissolved in water (giving a final solution of 0.5 M potassium acetate, pH 7.5) and split into 2 portions, which were incubated with the 5-phosphatase under conditions in which hydrolysis of the available Ins(1,3,4,5)P 4 was between 50 and 90%. One sample was spiked with [ 32 P]Ins(1,3,4,5)P 4 , and the products were analyzed by anion exchange to determine the degradation of authentic Ins(1,3,4,5)P 4 . The other sample was analyzed by the radioligand displacement assay. The 2 assays gave similar results with 73% hydrolysis of the internal radiolabeled standard versus 85% loss of radioligand displacing activity (no significant loss was detected by either approach using boiled enzyme as control). These results confirm that the radioligand displacement assay detects only material present in alkalihydrolyzed total cell lipid extracts that is degraded by a specific 5-phosphatase preparation at a similar rate to authentic Ins(1,3,4,5)P 4 , strongly suggesting that the assay is specifically measuring the latter compound.
We next applied the assay to measurements of PtdIns(3,4,5)P 3 in control and insulin-stimulated 1321N1 astrocytoma cells in parallel with analysis of cells which had been labeled to isotopic equilibrium with [ 3 H]inositol as described previously (22) . The latter procedure allowed an independent assessment of the mass of PtdIns(3,4,5)P 3 which can be determined from the radioactivity recovered in this lipid and measurement of the specific radioactivity of the inositol lipid pool. The results from these experiments are shown in Table I . The basal levels of PtdIns(3,4,5)P 3 (2.16 Ϯ 1.0 pmol/well) increased approximately 5-fold upon stimulation with insulin (11.3 Ϯ 1.85 pmol/well). These values are remarkably close to those determined from the specific radioactivity measurements.
The use of wortmannin, a potent inhibitor of PI 3-kinases, gave further confirmation of the assay's specificity. In 1321N1 astrocytoma cells preincubated with wortmannin at a concentration of 100 nM, a dose which is considered to be selective for PI 3-kinases, the insulin-stimulated increase in PtdIns(3,4,5)P 3 was completely abolished. The radioligand displacement assay was also used for measurements on Rat-1 fibroblasts, rat adipocytes, and HEK 293 cells, which all showed wortmannin-sensitive increases in PtdIns(3,4,5)P 3 upon stimulation with platelet-derived growth factor or insulin (not shown).
Regulation of PtdIns (3, 4, 5 )P 3 Levels and PKB Activity in Skeletal Muscle after in Vivo Stimulation of Rats with Insulin-PKB is the cellular homologue of the v-Akt protein encoded in the genome of the Akt-8 retrovirus, isolated from a rodent T-cell lymphoma (30) . Some isoforms of PKB are significantly overexpressed in several types of cancer (17, 31, 32) . PKB is activated rapidly in response to a wide range of stimuli which also activate PI 3-kinase. A direct role for PI 3-kinase in the activation of PKB has been suggested by a combination of pharmacological and molecular genetic approaches (33-35) . Moreover, PtdIns(3,4,5)P 3 can bind directly to PKB although this in itself is not sufficient for activation (36) which requires 2 D. M. Hickinson and C. P. Downes, unpublished results.
FIG. 2.
PtdIns(3,4,5)P 3 production and PKB activation in response to insulin in rat skeletal muscle. PtdIns(3,4,5)P 3 was extracted from 1 g of powdered muscle, and PKB was immunoprecipitated from 500 g of muscle extract. The mass of PtdIns(3,4,5)P 3 and the activity of PKB were measured using three rats for each time point. Data were standardized for protein content using the method of Bradford and are expressed as fold stimulation over control levels. Similar results were obtained in 3 independent experiments. Ⅺ, PI 3-kinase; f, PKB.
phosphorylation of specific serine and threonine residues by an unidentified protein kinase. 3 Using the new assay it is possible to monitor PtdIns(3,4,5)P 3 levels in tissues and/or cells which are not suitable for labeling to high specific radioactivity. Thus we now report the first measurements of this lipid second messenger in an animal tissue, rat hind limb skeletal muscle, and compare the effects of intravenous injection of insulin on PtdIns(3,4,5)P 3 levels and PKB activity in the same tissue samples. The results are shown in Fig. 2 . PtdIns(3,4,5)P 3 levels increased approximately 3-fold, 5 min after insulin administration, remained elevated at 10 min, and returned to basal levels within 15 min. PKB activity was elevated up to 4-fold and followed a similar time course which persisted at 15 min, but also returned to basal levels within 30 min. The larger and more prolonged PKB response is compatible with the hypothesis that PI 3-kinase lies upstream of PKB in a pathway which serves to amplify this initial signal.
In summary, the present report establishes the feasibility of measuring PtdIns(3,4,5)P 3 in cell and tissue extracts by a method which avoids time-consuming chromatographic procedures and hazardous amounts of radioactivity. The specificity and precision of the assay was demonstrated enzymologically, using an enzyme which specifically degrades PtdIns(3,4,5)P 3 and Ins(1,3,4,5)P 4 ; pharmacologically, by showing that the signal detected by the assay was enhanced by agonists which stimulate PI 3-kinase in a wortmannin-sensitive manner; and by comparison with PtdIns(3,4,5)P 3 levels determined by an independent method. In addition to the ease of analysis, an important advance is the ability to monitor PtdIns(3,4,5)P 3 in animal tissues which are not suited to metabolic labeling procedures. As PtdIns(3,4,5)P 3 has been implicated as a critical signal in both normal and pathological growth control, an important application of the assay will be the measurement of this lipid in clinical samples such as tumor biopsies.
